AU3210500A - Controlling heart rate or blood pressure in patients co-medicated with phosphodiesterase inhibitors for treatment of impotence - Google Patents

Controlling heart rate or blood pressure in patients co-medicated with phosphodiesterase inhibitors for treatment of impotence

Info

Publication number
AU3210500A
AU3210500A AU32105/00A AU3210500A AU3210500A AU 3210500 A AU3210500 A AU 3210500A AU 32105/00 A AU32105/00 A AU 32105/00A AU 3210500 A AU3210500 A AU 3210500A AU 3210500 A AU3210500 A AU 3210500A
Authority
AU
Australia
Prior art keywords
impotence
medicated
patients
treatment
blood pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32105/00A
Inventor
William L. Matier
Ghanshyam Patil
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Selectus Pharmaceuticals Inc
Original Assignee
Selectus Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Selectus Pharmaceuticals Inc filed Critical Selectus Pharmaceuticals Inc
Publication of AU3210500A publication Critical patent/AU3210500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU32105/00A 1999-01-22 2000-01-20 Controlling heart rate or blood pressure in patients co-medicated with phosphodiesterase inhibitors for treatment of impotence Abandoned AU3210500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23558799A 1999-01-22 1999-01-22
US09235587 1999-01-22
PCT/US2000/001284 WO2000043012A1 (en) 1999-01-22 2000-01-20 Controlling heart rate or blood pressure in patients co-medicated with phosphodiesterase inhibitors for treatment of impotence

Publications (1)

Publication Number Publication Date
AU3210500A true AU3210500A (en) 2000-08-07

Family

ID=22886134

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32105/00A Abandoned AU3210500A (en) 1999-01-22 2000-01-20 Controlling heart rate or blood pressure in patients co-medicated with phosphodiesterase inhibitors for treatment of impotence

Country Status (2)

Country Link
AU (1) AU3210500A (en)
WO (1) WO2000043012A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10325813B4 (en) 2003-06-06 2007-12-20 Universitätsklinikum Freiburg Prophylaxis and / or therapy in portal hypertension
WO2017165688A1 (en) * 2016-03-23 2017-09-28 University Of Maryland, Baltimore Compositions and methods for genetically modifying myosin phosphatase target subunit (mypt1) gene for lowering blood pressure

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9301192D0 (en) * 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
US5536749A (en) * 1994-10-13 1996-07-16 Sl Pharmaceuticals, Inc. Method for attenuation of sympathetic nervous system activity or onset of migraine by selectively metabolized beta-blocking agents

Also Published As

Publication number Publication date
WO2000043012A1 (en) 2000-07-27

Similar Documents

Publication Publication Date Title
AU2003251567A1 (en) Dialysis system for treatment of vulnerable patients and methods of use
AU7094800A (en) Methods and apparatus for treating body tissues and bodily fluid vessels
AU5774100A (en) Method and apparatus for the noninvasive determination of arterial blood pressure
TW453189U (en) Disposable absorbent article for treatment of body fluid
AU2003257613A1 (en) Catheter for treating irregular heart pulse
AU2003300200A1 (en) Valve treatment catheter and methods
AU2604301A (en) Tnf inhibitors for the treatment of neurological, retinal and muscular disorders
AU2002341876A1 (en) Methods and devices for treating diseased blood vessels
AU2002367970A1 (en) Medical device for the treatment of a body vessel or another tubular structure in the body
HUP0104966A3 (en) A medical system and a method of controlling the system for use by a patient for medical self treatment
AU1200501A (en) Drug delivery catheters that attach to tissue and methods for their use
AU2002351397A1 (en) Systems and methods using vasoconstriction for improved thermal treatment of tissues
AU8026200A (en) Treatment of heart disease with cox-2 inhibitors
IL165834A0 (en) Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases
AU5739800A (en) Method for direct diagnosis and treatment of pain of muscular origin
GB0020504D0 (en) Therapeutic method
AU3896900A (en) Treatment of pain
AU3210500A (en) Controlling heart rate or blood pressure in patients co-medicated with phosphodiesterase inhibitors for treatment of impotence
AU2001251489A1 (en) Assembly for extracorporeal blood handling and method of use
AU2001232053A1 (en) System for the extracorporeal treatment of blood
AU9545701A (en) Use of carp inhibitors for the treatment of heart diseases
AU2001246754A1 (en) Central venous line catheter and method of preparing the same for the use
WO2001007038A3 (en) Use of l-carnitine and its alkanoyl derivatives for the preparation of a medicament useful for the treatment of patients suffering from diabetic and/or dysmetabolic nephropathy
AU2002322301A1 (en) Methods for the diagnosis and treatment of cardiac tissue rejection
EP1157705A3 (en) Use of a phosphodiesterase inhibitor in the manufacture of a medicament for blood pressure stabilization during hemodialysis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase